Cargando…
Neuroinflammation and α-Synuclein Dysfunction Potentiate Each Other, Driving Chronic Progression of Neurodegeneration in a Mouse Model of Parkinson’s Disease
BACKGROUND: Mechanisms whereby gene–environment interactions mediate chronic, progressive neurodegenerative processes in Parkinson’s disease (PD)—the second most common neurodegenerative disease—remain elusive. OBJECTIVE: We created a two-hit [neuroinflammation and mutant α-synuclein (α-syn) overexp...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
National Institute of Environmental Health Sciences
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3114815/ https://www.ncbi.nlm.nih.gov/pubmed/21245015 http://dx.doi.org/10.1289/ehp.1003013 |
_version_ | 1782206119403323392 |
---|---|
author | Gao, Hui-Ming Zhang, Feng Zhou, Hui Kam, Wayneho Wilson, Belinda Hong, Jau-Shyong |
author_facet | Gao, Hui-Ming Zhang, Feng Zhou, Hui Kam, Wayneho Wilson, Belinda Hong, Jau-Shyong |
author_sort | Gao, Hui-Ming |
collection | PubMed |
description | BACKGROUND: Mechanisms whereby gene–environment interactions mediate chronic, progressive neurodegenerative processes in Parkinson’s disease (PD)—the second most common neurodegenerative disease—remain elusive. OBJECTIVE: We created a two-hit [neuroinflammation and mutant α-synuclein (α-syn) overexpression] animal model to investigate mechanisms through which mutant α-syn and inflammation work in concert to mediate chronic PD neurodegeneration. METHODS: We used an intraperitoneal injection of the inflammogen lipopolysaccharide (LPS; 3 × 10(6) EU/kg) to initiate systemic and brain inflammation in wild-type (WT) mice and transgenic (Tg) mice overexpressing human A53T mutant α-syn. We then evaluated nigral dopaminergic neurodegeneration, α-syn pathology, and neuroinflammation. RESULTS: After LPS injection, both WT and Tg mice initially displayed indistinguishable acute neuroinflammation; however, only Tg mice developed persistent neuroinflammation, chronic progressive degeneration of the nigrostriatal dopamine pathway, accumulation of aggregated, nitrated α-syn, and formation of Lewy body-like inclusions in nigral neurons. Further mechanistic studies indicated that 4-week infusion of two inhibitors of inducible nitric oxide synthase and NADPH oxidase, major free radical–generating enzymes in activated microglia, blocked nigral α-syn pathology and neurodegeneration in LPS-injected Tg mice. CONCLUSIONS: Microglia-derived oxidative stress bridged neuroinflammation and α-syn pathogenic alteration in mediating chronic PD progression. Our two-hit animal model involving both a genetic lesion and an environmental trigger reproduced key features of PD and demonstrated synergistic effects of genetic predisposition and environmental exposures in the development of PD. The chronic progressive nature of dopaminergic neurodegeneration, which is absent in most existing PD models, makes this new model invaluable for the study of mechanisms of PD progression. |
format | Online Article Text |
id | pubmed-3114815 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | National Institute of Environmental Health Sciences |
record_format | MEDLINE/PubMed |
spelling | pubmed-31148152011-06-16 Neuroinflammation and α-Synuclein Dysfunction Potentiate Each Other, Driving Chronic Progression of Neurodegeneration in a Mouse Model of Parkinson’s Disease Gao, Hui-Ming Zhang, Feng Zhou, Hui Kam, Wayneho Wilson, Belinda Hong, Jau-Shyong Environ Health Perspect Research BACKGROUND: Mechanisms whereby gene–environment interactions mediate chronic, progressive neurodegenerative processes in Parkinson’s disease (PD)—the second most common neurodegenerative disease—remain elusive. OBJECTIVE: We created a two-hit [neuroinflammation and mutant α-synuclein (α-syn) overexpression] animal model to investigate mechanisms through which mutant α-syn and inflammation work in concert to mediate chronic PD neurodegeneration. METHODS: We used an intraperitoneal injection of the inflammogen lipopolysaccharide (LPS; 3 × 10(6) EU/kg) to initiate systemic and brain inflammation in wild-type (WT) mice and transgenic (Tg) mice overexpressing human A53T mutant α-syn. We then evaluated nigral dopaminergic neurodegeneration, α-syn pathology, and neuroinflammation. RESULTS: After LPS injection, both WT and Tg mice initially displayed indistinguishable acute neuroinflammation; however, only Tg mice developed persistent neuroinflammation, chronic progressive degeneration of the nigrostriatal dopamine pathway, accumulation of aggregated, nitrated α-syn, and formation of Lewy body-like inclusions in nigral neurons. Further mechanistic studies indicated that 4-week infusion of two inhibitors of inducible nitric oxide synthase and NADPH oxidase, major free radical–generating enzymes in activated microglia, blocked nigral α-syn pathology and neurodegeneration in LPS-injected Tg mice. CONCLUSIONS: Microglia-derived oxidative stress bridged neuroinflammation and α-syn pathogenic alteration in mediating chronic PD progression. Our two-hit animal model involving both a genetic lesion and an environmental trigger reproduced key features of PD and demonstrated synergistic effects of genetic predisposition and environmental exposures in the development of PD. The chronic progressive nature of dopaminergic neurodegeneration, which is absent in most existing PD models, makes this new model invaluable for the study of mechanisms of PD progression. National Institute of Environmental Health Sciences 2011-06 2011-01-18 /pmc/articles/PMC3114815/ /pubmed/21245015 http://dx.doi.org/10.1289/ehp.1003013 Text en http://creativecommons.org/publicdomain/mark/1.0/ Publication of EHP lies in the public domain and is therefore without copyright. All text from EHP may be reprinted freely. Use of materials published in EHP should be acknowledged (for example, ?Reproduced with permission from Environmental Health Perspectives?); pertinent reference information should be provided for the article from which the material was reproduced. Articles from EHP, especially the News section, may contain photographs or illustrations copyrighted by other commercial organizations or individuals that may not be used without obtaining prior approval from the holder of the copyright. |
spellingShingle | Research Gao, Hui-Ming Zhang, Feng Zhou, Hui Kam, Wayneho Wilson, Belinda Hong, Jau-Shyong Neuroinflammation and α-Synuclein Dysfunction Potentiate Each Other, Driving Chronic Progression of Neurodegeneration in a Mouse Model of Parkinson’s Disease |
title | Neuroinflammation and α-Synuclein Dysfunction Potentiate Each Other, Driving Chronic Progression of Neurodegeneration in a Mouse Model of Parkinson’s Disease |
title_full | Neuroinflammation and α-Synuclein Dysfunction Potentiate Each Other, Driving Chronic Progression of Neurodegeneration in a Mouse Model of Parkinson’s Disease |
title_fullStr | Neuroinflammation and α-Synuclein Dysfunction Potentiate Each Other, Driving Chronic Progression of Neurodegeneration in a Mouse Model of Parkinson’s Disease |
title_full_unstemmed | Neuroinflammation and α-Synuclein Dysfunction Potentiate Each Other, Driving Chronic Progression of Neurodegeneration in a Mouse Model of Parkinson’s Disease |
title_short | Neuroinflammation and α-Synuclein Dysfunction Potentiate Each Other, Driving Chronic Progression of Neurodegeneration in a Mouse Model of Parkinson’s Disease |
title_sort | neuroinflammation and α-synuclein dysfunction potentiate each other, driving chronic progression of neurodegeneration in a mouse model of parkinson’s disease |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3114815/ https://www.ncbi.nlm.nih.gov/pubmed/21245015 http://dx.doi.org/10.1289/ehp.1003013 |
work_keys_str_mv | AT gaohuiming neuroinflammationandasynucleindysfunctionpotentiateeachotherdrivingchronicprogressionofneurodegenerationinamousemodelofparkinsonsdisease AT zhangfeng neuroinflammationandasynucleindysfunctionpotentiateeachotherdrivingchronicprogressionofneurodegenerationinamousemodelofparkinsonsdisease AT zhouhui neuroinflammationandasynucleindysfunctionpotentiateeachotherdrivingchronicprogressionofneurodegenerationinamousemodelofparkinsonsdisease AT kamwayneho neuroinflammationandasynucleindysfunctionpotentiateeachotherdrivingchronicprogressionofneurodegenerationinamousemodelofparkinsonsdisease AT wilsonbelinda neuroinflammationandasynucleindysfunctionpotentiateeachotherdrivingchronicprogressionofneurodegenerationinamousemodelofparkinsonsdisease AT hongjaushyong neuroinflammationandasynucleindysfunctionpotentiateeachotherdrivingchronicprogressionofneurodegenerationinamousemodelofparkinsonsdisease |